Burkehill Global Management, LP

Source: SEC Form 13F · as of Mar 2026

Burkehill Global Management, LP holds 68 biotech & pharma companies tracked by BioSniper, totaling $335.7M in value as of Mar 2026 (SEC Form 13F).

Companies held

68

Total value held

$335.7M

CompanySharesValue
LLYELI LILLY & Co145,000$133.4M
COGTCogent Biosciences, Inc.675,000$26.0M
GHGuardant Health Inc.150,000$13.9M
PRAXPraxis Precision Medicines, Inc.35,000$11.3M
RAPPRapport Therapeutics, Inc.250,000$7.8M
NUVLNuvalent, Inc.70,000$7.2M
TRVITrevi Therapeutics, Inc.525,000$6.3M
KYMRKymera Therapeutics, Inc.75,000$6.2M
ALHCAlignment Healthcare Inc.350,000$6.2M
CNTACentessa Pharmaceuticals plc150,000$6.0M
XENEXenon Pharmaceuticals Inc.100,000$5.8M
IMNMImmunome Inc.200,000$4.4M
BHVNBiohaven Ltd.500,000$4.2M
DNTHDianthus Therapeutics, Inc. /DE/50,000$4.2M
MLYSMineralys Therapeutics, Inc.150,000$4.1M
DNLIDenali Therapeutics Inc.200,000$3.8M
CMPXCompass Therapeutics, Inc.700,000$3.7M
ALMSALUMIS INC.165,000$3.6M
CRNXCrinetics Pharmaceuticals, Inc.100,000$3.6M
IRONDisc Medicine, Inc.50,000$3.2M
MBXMBX Biosciences, Inc.100,000$3.0M
PCVXVaxcyte, Inc.50,000$2.9M
GPCRStructure Therapeutics Inc.60,000$2.9M
DYNDyne Therapeutics, Inc.155,000$2.8M
IMMXImmix Biopharma, Inc.294,118$2.7M
FDMT4D Molecular Therapeutics, Inc.275,000$2.6M
APGEApogee Therapeutics, Inc.30,000$2.5M
TARAProtara Therapeutics, Inc.450,000$2.3M
AVBPArriVent BioPharma, Inc.100,000$2.3M
SHCSotera Health Company150,000$2.2M
TERNTerns Pharmaceuticals, Inc.40,000$2.1M
BCAXBicara Therapeutics Inc.100,000$2.0M
DFTXDefinium Therapeutics Inc.100,000$1.9M
CABACabaletta Bio, Inc.700,000$1.9M
OLMAOlema Pharmaceuticals, Inc.125,000$1.9M
NRIXNurix Therapeutics, Inc.118,972$1.8M
STROSUTRO BIOPHARMA, INC.71,530$1.8M
BIOABioAge Labs, Inc.100,000$1.7M
KYTXKyverna Therapeutics, Inc.200,000$1.7M
ERASErasca, Inc.100,000$1.6M
BNTCBenitec Biopharma Inc.150,000$1.6M
IMRXImmuneering Corp300,000$1.6M
MPLTMapLight Therapeutics, Inc.75,000$1.5M
IMTXImmatics N.V.150,000$1.5M
CMPSCOMPASS Pathways plc250,000$1.4M
CBIOCRESCENT BIOPHARMA, INC.74,000$1.4M
LRMRLarimar Therapeutics, Inc.300,000$1.4M
CAICaris Life Sciences Inc.75,000$1.3M
VRDNViridian Therapeutics, Inc.\DE65,000$1.3M
EIKNEikon Therapeutics Inc.115,000$1.2M
EVMNEvommune, Inc.50,000$1.1M
ESPREsperion Therapeutics, Inc.400,000$1.1M
WVEWave Life Sciences Ltd.150,000$1.1M
RCUSArcus Biosciences, Inc.50,000$1.1M
CTMXCytomX Therapeutics, Inc.225,000$1.1M
KMTSKestra Medical Technologies Ltd.50,000$997K
PHATPhathom Pharmaceuticals, Inc.75,000$833K
ZBIOZenas BioPharma, Inc.40,000$782K
RLMDRELMADA THERAPEUTICS, INC.105,263$665K
ATAIAtai Beckley N.V.185,000$655K
ZURAZura Bio Ltd75,000$446K
ACETAdicet Bio, Inc.62,500$426K
FULCFulcrum Therapeutics, Inc.50,000$384K
AGMBAgomAb Therapeutics NV35,000$367K
CNTBConnect Biopharma Holdings Ltd150,000$360K
MANEVeradermics Incorporated5,000$316K
CRVSCorvus Pharmaceuticals, Inc.20,000$293K
GUTSFractyl Health Inc.500,000$229K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Burkehill Global Management, LP — Biotech 13F Holdings & Portfolio | BioSniper